Funding Round
Precision Neuroscience raises $102M Series C to scale Layer 7 BCI implant manufacturing
STAT News4/22/2026·04/22/26🌐 USA
Summary
Precision Neuroscience closed a $102M Series C led by General Catalyst with participation from Microsoft M12 and Forepont Capital. The raise brings total funding to $155M. Funds will support FDA De Novo application for the Layer 7 Cortical Interface and expansion of their minimally invasive implantation procedure training program for neurosurgeons.
Why it matters
Precision's rapid fundraising cadence — three rounds in two years — reflects strong investor confidence in their slit-craniotomy approach as a less invasive alternative to Neuralink's robotic implantation. The General Catalyst lead also signals healthcare commercialization expertise.
#BCI#Industry#Neural Interfaces#Neurostimulation#USA#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in